Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy
This prospective imaging study is evaluating the feasibility of using the Halcyon 4.0 radiotherapy system for radiation therapy planning in patients with cancer. The Halcyon 4.0 system has been engineered to decrease the image acquisition time and the radiation exposure, but the system has not yet been clinically validated for use in radiation planning. This pilot study will evaluate images obtained on the Halcyon 4.0 system to assess if the quality is sufficient for radiation treatment plan construction.
Checked against the public recordLast updated Oct 21, 2024 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Device Feasibility
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Washington University School of Medicine
- Interventions being studied
- Device: Halcyon 4.0 system
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Eligibility Criteria: * Planning to receive radiation therapy to one of the following sites: * Head and neck/brain (n=10) * Thorax (n=10) * Abdomen (n=10) * Pelvis (n=10) * At least 18 years of age * If the patient will be receiving IV contrast on study: Adequate renal function as defined by a serum creatinine \< 1.4, or, for patients with chronic kidney disease, a stable serum creatinine \< 2.0. Note: if no IV contrast will be administered on study, patient may enroll without creatinine level documented. * If the patient is a woman of childbearing potential, a negative pregnancy test must be obtained. Contraceptive use is not an adequate documentation of no chance of pregnancy. * Able to understand and willing to sign an IRB approved written informed consent document.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Washington University School of MedicineSt Louis, Missouri
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 21, 2024. Always confirm current availability with the study team.